Colon cancer​ patients saw improved survival rates after a 3-year exercise program, according to a first-of-its-kind ...

Multiple myeloma is considered incurable, but a third of patients in a Johnson & Johnson clinical trial have lived without ...

Learn how colon cancer patients can reap the benefits of exercise, potentially raising the chances of survival post-surgery ...

The world’s largest meeting on cancer research has brought promising updates on treatment and prevention for colorectal ...

New hope is on the horizon in the fight against cancer. At this year’s American Society of Clinical Oncology (ASCO) annual ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news ...

Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer ...

Groundbreaking research shows exercise reduces cancer death risk by 37% and recurrence by 28%, proving more effective than ...

The Trump administration's proposed funding cuts to the National Institutes of Health (NIH), including the National Cancer ...

With the American Society of Clinical Oncology (ASCO) annual meeting in full swing at Chicago’s McCormick Place this past ...

AstraZeneca Plc (NASDAQ:AZN) on Monday released results from three Phase 3 clinical trials at the 2025 American Society of ...

Abstracts published ahead of the 2025 American Society of Clinical Oncology Annual Meeting found persistent ovarian cancer survival disparities among racial and ethnic subgroups, particularly ...